LY75 and Chorioretinal atrophy: Both the inflammatory changes and the associated retinal degeneration (chorioretinal atrophy) are markedly reduced by treatment with DEC205-HEL fusion protein while DCIR2-HEL fusion protein is less effective in suppressing both inflammation and atrophy.